RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...

Goldman Sachs would consider acquisitions in asset and wealth management, but would be highly selective about any deal, CEO ...

Goldman Sachs Group Inc.’s growth equity unit led a $125 million funding round for software startup Tines Security Services ...

Employees’ privileged access to its own funds show a widening compensation gap on Wall Street. Marc Rubinstein is a former ...

Private equity firm Turn/River Capital has agreed to acquire SolarWindsin, a provider of secure observability and IT ...

We recently compiled a list of the 10 Best Stocks to Invest in According to AI. In this article, we are going to take a look ...

SolarWinds (SWI, Financials), a provider of IT management and observability software, has agreed to be acquired by Turn/River ...

The rise of artificial intelligence in finance has led many investors to question whether AI-powered tools like ChatGPT can ...

IBM's was the standout deal of the week — Reverse Yankee or otherwise in the single currency. The issuer priced a €3.5bn ...

The stress test, which will include 22 banks compared to last year’s 32, will feature two added hypothetical elements for the ...

In a report released today, Anke Reingen from RBC Capital maintained a Hold rating on ING GROEP (0RIC – Research Report), with a price target ...

Investors are seeking to protect portfolios from the potential economic fallout from President Donald J. Trump’s tariff plans even as many on Wall Street doubt the situation will erupt into a ...